Inventor · disambiguated record
Yaning Su
Also filed as: SU YANING
7 granted patents·8 pending applications·10 citations·filing 2017–2023
76Inventor score
Top patents by PatentIndex Score
15 records- 0185US9974762B2Necrosis inhibitorsNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2017·Granted May 22, 2018·6 cites·20 claims
- 0284US10092529B2Necrosis inhibitorsNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2017·Granted Oct 9, 2018·4 cites·20 claims
- 0364US11478438B2Necrosis inhibitorsNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2020·Granted Oct 25, 2022·0 cites·22 claims
- 0460US10555920B2Necrosis inhibitorsNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2018·Granted Feb 11, 2020·0 cites·32 claims
- 0559US10682319B2Necrosis inhibitorsNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2018·Granted Jun 16, 2020·0 cites·12 claims
- 0658US2024391900A1Rip1 kinase inhibitor and use thereofSIRONAX BEIJING CO LTD·Filed 2022·Application pending·0 cites
- 0754US12129221B2Difluoro phenyl amide RIP1 inhibitorSIRONAX LTD·Filed 2021·Granted Oct 29, 2024·0 cites·4 claims
- 0854US2024409501A1Cyrstalline forms of rip1 inhibitorSIRONAX LTD·Filed 2022·Application pending·0 cites
- 0954US2025179061A1Rip1 modulators, preparations, and uses thereofSIRONAX LTD·Filed 2023·Application pending·0 cites
- 1050US12454529B2Piperazine cyclic ureasSIRONAX LTD·Filed 2021·Granted Oct 28, 2025·0 cites·28 claims
- 1150US2024217963A1Receptor-interacting protein 1 inhibitors, preparations, and uses thereofSIRONAX LTD·Filed 2022·Application pending·0 cites
- 1250US2024294508A1Rip1 modulators including azetidine cyclic ureas, preparations, and uses thereofSIRONAX LTD·Filed 2022·Application pending·0 cites
- 1347US2021292305A1Cyclic UreasSIRONAX LTD·Filed 2021·Application pending·0 cites
- 1446US2023416226A1Azetidine Cyclic UreasSIRONAX LTD·Filed 2021·Application pending·0 cites
- 1546US2023192662A1Receptor-Interacting Protein 1 Inhibitors Including Piperazine Heterocyclic Amide UreasSIRONAX LTD·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →